Increased PD-L1+CD20+ % were observed in DLBCL patients compared to healthy volunteers (median 9.5 [range: 6.7–16] % vs. median 1.0 [range: 0.8–1] %, p < 0.001). The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.